Bordetella bronchiseptica chronically infects a wide range of mammals, and resides primarily in the nasal cavity of the infected host. Multiple virulence factors of Bordetella species have been studied in the context of lower respiratory tract infections, but relatively less is known about the bacterial life cycle in the nasal cavity. Evidences were discovered for Bvg intermediate (Bvg i ) phase expression in vivo and that the major adhesin filamentous hemagglutinin plays a major role in the colonization of B. bronchiseptica in the unciliated olfactory epithelia of the nasal cavity.
Introduction
Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica are closely related Gram-negative species that colonize the upper respiratory tract of mammals and mainly cause pathogenic symptoms in the lower respiratory tract. Bordetella pertussis and most B. parapertussis strains only infect humans and generally cause acute respiratory diseases (Bjrnstad & Harvill, 2005) . Bordetella bronchiseptica often causes persistent chronic infections in a wide range of mammalian host and colonizes the hosts for their lifetimes (Mattoo & Cherry, 2005) . Despite the differences in host niches and symptoms due to infections by the Bordetella species, most virulence factors are highly conserved.
A majority of Bordetella virulence factors are transcriptionally controlled by a two-component system BvgAS (Bordetella virulence genes). The response regulator BvgA has different binding specificities to certain promoters of virulence factors depending on its phosphorylation status as modulated by the sensor histidine kinase BvgS (Cotter & Jones, 2003) . In the virulent Bvg 1 phase, toxins/toxin delivery systems such as pertussis toxin, adenylate cyclase/ hemolysin bifunctional toxin (CyaA), dermonecrotic toxin, and type III secretion system are being expressed. Adhesins such as filamentous hemagglutinin (FHA) and fimbriae are also highly expressed. In the avirulent Bvg À phase, the virulence factors are not expressed (Mattoo & Cherry, 2005) . Bvg modulations are thought to affect profiles of gene transcriptions in a gradual range of changes (Cummings et al., 2006) . Between Bvg 1 and Bvg À phases is at least one distinct phase named the Bvg intermediate phase (Bvg i ) (Cotter & Miller, 1997) , expressing a different set of gene products from Bvg 1 and Bvg À phases. Genes such as bipA are upregulated specific to the Bvg i phase, as well as the adhesins such as FHA and fimbriae that are expressed at both Bvg 1 and Bvg i phases.
The effects of CyaA and type III secretion system on host cells are well-characterized and are the primary causes for in vitro cytotoxicity (Cotter et al., 1998; Yuk et al., 2000; Vojtova et al., 2006) . In addition, they interfere with the host immune systems to facilitate the successful infection of the host (Skinner et al., 2004; Reissinger et al., 2005; Vojtova et al., 2006) . FHA possesses at least four binding domains involved in attachment including the Arg-Gly-Asp (RGD) triplet, the leukocyte response integrin/integrin-associated protein (LRI/IAP) complex, the complement receptor type 3 (CR3) and the carbohydrate recognition domain (CRD) (Relman et al., 1990; Saukkonen et al., 1991; Prasad et al., 1993; Ishibashi et al., 1994) . FHA has been characterized as the major adhesin that mediates binding to the cilia of the respiratory epithelial cells by the CRD domain (Prasad et al., 1993) . In addition, it was previously shown that FHA is largely responsible for mediating biofilm formation (Irie et al., 2004) .
A majority of the reported research on Bordetella pathogenesis has focused on the infection of the lower respiratory tract. However, the primary host reservoir for B. bronchiseptica colonization is thought to be the nasal cavity. Bvg phase regulation is sensitive to temperature (Cotter & Jones, 2003) , with the Bvg 1 phase being expressed at 37 1C while the Bvg À phase is predominant at 25 1C and below. The mammalian mucosal temperature in the nasal cavity has been estimated to be $30 1C (Jacky, 1980) , which supports a Bvg i phase growth (Williams et al., 2005) . In the Bvg i phase, toxins are not expressed, but the adhesins are. We report in this study that FHA plays a major role in the colonization of the nasal cavity, and provide indirect evidence that the bacteria are in the Bvg i phase in the nose.
Materials and methods

Bacterial strains and growth conditions
Bordetella bronchiseptica strains RB50 [wild type (WT)], RB53 (Bvg 1 phase-locked mutant), RB53i (Bvg i phaselocked mutant), and RBX9 (DfhaB) were previously reported and characterized (Cotter & Miller, 1994 Cotter et al., 1998) . Bordetella bronchiseptica strains were propagated in Stainer-Scholte (Stainer & Scholte, 1970) liquid medium or on BG agar (Becton Dickinson) supplemented with defibrinated sheep blood at 37 1C.
Animal colonization
High-dose intranasal infections of anesthetized mice and recovery of bacteria were performed as previously described (Harvill et al., 1999) and at least three mice per experiment were used. C57/BL6 mice aged 6-10 weeks old were obtained from the National Cancer Institute and housed in insulator cages and cared for in accordance with Institutional Animal Care and Use Committee-approved protocols at the University of Pennsylvania School of Medicine animal facility. For tissue sectioning, sacrificed mice were bled by cardiac puncture before decapitation. For bacterial counts, CFU were determined by plating serially diluted homogenized lungs and vortexed trachea and nasal cavity tissue materials.
Tissue sections
Soft tissues were surgically removed from the skulls of decapitated heads. The skulls were then immersed in 4% paraformaldehyde phosphate-buffered saline (PBS) solution for 24 h, gently washed with water, and decalcified in Decal solution (Decal Chemical Corp) for 24 h. Skulls were then imbedded in Tissue-Tek O.C.T. (Sakura) before freezing in 2-methylbutane immersed in liquid nitrogen. Samples were sectioned at $10 mm thickness with cryotome blades and mounted on glass microscopy slides.
Immunofluorescence
Frozen sections were fixed in acetone at 4 1C for 10 min. They were then rehydrated in PBS, incubated in 0.1% sodium borohydride for 15 min. Sera from three mice infected with WT B. bronchiseptica for 100 days were pooled after retro-orbital bleeding and centrifuging and used as primary antibodies for the stains. Secondary antibodies used were Alexa Fluor 594-conjugated goat anti-mouse IgG (Molecular Probes). Samples were incubated with each solution of antibodies diluted 1 : 500 in PBS for 30 min each at room temperature. After each incubation step, samples were washed three times with PBS.
Hematoxylin & eosin (H&E) staining
Frozen sections were first washed in water for 3 min. They were then stained with hematoxylin solution (Surgipath) for 2 min. followed by a wash step under running tap water for 2 min. The slides were exposed to 50% ethanol for 1 min and then stained with eosin solution (Surgipath) for 1 min. The slides were rehydrated in alcohol ascending battery (from 70% to 100%) 1 min per step. Slides were then cleared with xyline (Surgipath) and a coverslip was applied using Permount medium (Fisher).
Microscopy
All fluorescence images were taken using Improvision Open Lab software and a Leica DM R epifluorescence microscope. Deconvolution was performed on all images using Improvision Volocity.
Results
The biology of B. bronchiseptica in the nasal cavities of infected hosts has not been extensively characterized. From previous reports, Bvg À phase-locked mutants were completely deficient in colonization (Cotter & Miller, 1997) , and DfhaB mutants (functional deletion of FHA) had lower CFU recovered from dissected nasal cavity tissue materials (Cotter et al., 1998) . To investigate colonization patterns throughout the nasal cavity, tissue sections were carried out at different intervals of the murine skulls along the anterial-posterial axis. The different section intervals, based on a previous histological description (Uraih & Maronpot, 1990) , were examined according to structural hallmarks at each region of the nasal cavity. Level 1 is the most anterior region of the nasal cavity, closest to the nares. The most significant differences between the different levels are the types of epithelial cells lining the mucosa. The primary observation is that there is a significant transition from ciliated respiratory epithelia to the nonciliated olfactory epithelia qas progression is made into the nasal cavity toward the posterior end of the skull. The epithelial cell types of the specific nasal structures at various interval sections of the nasal cavity, as described by an earlier study (Uraih & Maronpot, 1990) , are summarized in the first four columns of Table 1 .
FHA mutants are unable to colonize nonciliated olfactory epithelia
Upon studying WT and DfhaB-infected murine nasal cavities by immunofluorescence microscopy of tissue sections, it was apparent that DfhaB mutants were incapable of colonizing areas of the nasal cavity that consist primarily of nonciliated olfactory epithelia (Table 1 and Fig. 1 ). Interestingly, all strains of B. bronchiseptica were absent at the most anterior end of the tissue sections (Level 1). The colonization profiles of WT and DfhaB bacteria on the respiratory and transitional epithelia at Level 2 and 2.5, however, were identical (Table 1 and Fig. 2 ). Colonizing WT bacteria ultimately grew into large three-dimensional structures after 7 days of infection (Fig. 1e) . The enlarged image of one of these microcolonies clearly shows that this is a structured bacterial aggregate (Fig. 1h) . By H&E stain of an adjacent tissue section (Fig. 1i) , there appear to be no superficial damages to the host epithelia in the area of B. bronchiseptica colonization or any neutrophil infiltration that can contribute to the observed microcolony structures. Similar microcolony formations have been observed previously in vitro for B. bronchiseptica biofilms (Irie et al., 2004) . It is possible that the colonizing bacteria are growing in a biofilm-like state. FHA of Bordetella has been characterized to have specific binding affinities to the cilia of mammalian respiratory cells (Smith et al., 2001) . The absence of DfhaB in the olfactory epithelia implicates that binding to these tissues in vivo is FHA-dependent but not cilia-mediated. FHA has also been shown to mediate binding to nonciliated cells such as macrophages (Saukkonen et al., 1991) , and possesses at least four independent binding domains involved in attachment (Mattoo & Cherry, 2005) . As colonizations of the nasal respiratory epithelia by WT and DfhaB appear to be indistinguishable (Table 1 and Fig. 2 ), this suggests that the binding to these ciliated cell types is FHA-independent.
Further supporting the data observed by microscopy, the quantities of DfhaB mutants recovered from dissected nasal cavity tissue materials of mice were slightly less than those from WT-infected animals at 7 days postinfection ( Fig. 3 ; p % 0.0126), consistent with previous studies carried out in rats (Cotter et al., 1998) . At this time point, significant numbers of microcolonies in WT-infected samples but none from samples infected by the DfhaB mutant could be observed. The DfhaB bacteria recovered from the nasal cavity probably represented those that were colonizing the nasal respiratory epithelium. It is unclear why at 3 days postinfection, WT and DfhaB mutants were recovered in similar CFU. It is possible that the enlargement of the microcolony structures is required to reflect differences in the log scale. (a)
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Evidences for the expression of the Bvg i phase in vivo
Bvg i phase in vitro has previously been characterized as important for surface attachment and biofilm formation (Irie et al., 2004) . Biofilm formation is FHA dependent, leading one to investigate whether the in vitro phenotype is related to observed bacterial colonization in vivo, which is also FHA dependent and is in a microscopically biofilm-like state. The expression of the Bvg i phase in vivo has been controversial for some time, and it has been unclear as to whether the Bvg i phase is part of the pathogenic life cycle of B. bronchiseptica (Vergara-Irigaray et al., 2005). The major challenge has been that BipA (function and in vivo expression unknown) is currently the only characterized gene product specific to the Bvg i phase and not to the Bvg 1 or Bvg À phase (Stockbauer et al., 2001) . WT-infected nasal cavity tissue sections did not demonstrate the presence of BipA when they were stained with antibodies raised against BipA (data not shown). Since close examinations were not carried out for nasal cavity B. bronchiseptica colonization in the past, an attempt was made to investigate the specific Bvg phase the bacteria were expressing in the nasal cavity. From earlier studies, Bvg À phase-locked strains are completely deficient in colonization of the host (Cotter & Miller, 1994) and there are strong evidences that Bvg À phase is not expressed during colonization (Cotter & Miller, 1994; Akerley et al., 1995) . Mice were then infected with Bvg 1 phaselocked mutants (RB53). From the immunofluorescence images (Fig. 4a) , it seemed that this mutant could form microcolonies, but upon inspecting the H&E stain of an adjacent section, it was discovered that it was caused by major perturbations of the host epithelial tissue at the sites of colonized bacteria (Fig. 4b) instead of by threedimensional bacterial aggregates. Various toxins such as adenylate cyclase/hemolysin toxin and the type III secretion effector(s) such as BteA/BopC (Panina et al., 2005; Kuwae et al., 2006) that cause cytotoxicity to mammalian cells are only expressed in the Bvg 1 phase. It is possible that the expression of such toxins by RB53 in the nasal cavity was causing such damage to the host tissue. Because such damage to the host tissue by WT bacteria was not observed (Fig. 1e  and i) , it is probable that WT B. bronchiseptica are not expressing the Bvg 1 phase in the nasal cavity. In order to confirm whether colonized bacteria are expressing the Bvg i phase, mice were also infected with Bvg i phase-locked mutants (RB53i). However, consistent with previously published results, RB53i colonizes the respiratory tract including the nasal cavity poorly compared with WT (Cotter & Miller, 1997) , indicating that intact Bvg phase switch mechanism is required for the successful maximum establishment of bacterial colonization. Because RB53i has been characterized to hyper-aggregate (Cotter & Miller, 1997; Stockbauer et al., 2001) , traditional CFU counts on solid media may be largely under-represented. However, there appeared to be fewer bacterial microcolonies in the nasal cavity compared with WT, complementing quantitative bacterial counts from dissected tissues (data not shown). Because colonization levels are different between RB53i and WT, direct comparison is difficult to accomplish, indicating that RB53i is not appropriate for in vivo studies of the Bvg i phase. Despite this difficulty, RB53i found in the nasal cavity was found to form similar sizes of microcolony structures on the nasal mucosa (data not shown), indicating that the lower RB53i CFU was not due to a structural aggregation defect, but possibly due to insufficient surface inoculation coverage during infection, defect in initial attachment (highly unlikely, given the enhanced attachment properties of RB53i), defect in competition against other resident species on the nasal mucosa, and/or defect in survival of RB53i against host immune system.
Absence of B. bronchiseptica was observed at Level 1 sections, possibly due to the lower temperature of the surface mucosa near the nares, as the air is most likely representative of ambient temperature. At such temperature, B. bronchiseptica expresses the Bvg À phase and may be incapable of attachment and other factors necessary to establish colonization, as B. bronchiseptica was also not seen infecting Level 1 sections at an earlier time point (Day 1 postinfection data not shown). Alternatively, B. bronchiseptica may be experiencing niche competition against commensal species heavily colonizing the areas of the nasal cavity closest to the outside.
Discussion
Results from this study reveal interesting observations of B. bronchiseptica colonization of the nasal cavity, an underresearched site of B. bronchiseptica pathogenesis despite being widely believed to be the primary site of environmental reservoir. WT bacteria were observed to form threedimensional microcolony aggregates on nasal epithelia, resembling in vitro biofilm microcolonies (Irie et al., 2004) . While WT bacteria were able to colonize ciliated respiratory epithelia and nonciliated olfactory epithelia, FHA mutants were only able to colonize ciliated respiratory epithelia. This result indicates that FHA is an important factor for adhesion to nonciliated epithelia, but adhesion to ciliated epithelia is FHA independent. FHA has been associated with cilia adhesion in previous publications (Smith et al., 2001) , but all studies have been carried out with tracheal ciliated epithelia cells (Edwards et al., 2005) . Based on the discrepancies between the results described in this report and previous publications, it is highly likely that there are physiological differences between the cilia found in the nasal cavity and the trachea. However, no publications could be found comparing the two, as there are very few studies focusing on cell biology of the nasal cavity epithelia. FHA adhesion to ciliated nasal epithelial cells (not exclusively to cilia themselves) has been suggested previously (Register & Ackermann, 1997) , but in vitro data on cultured nasal epithelia might not be completely representative of in vivo host-pathogen interactions. FHA-dependent aggregation and adhesion have been demonstrated for biofilm formation in vitro. Because maximal biofilm formation has been observed when B. bronchiseptica is expressing the Bvg i phase (Irie et al., 2004) suggests the expression of the Bvg i phase. However, the possibility that B. bronchiseptica are expressing an entirely different Bvg phase in vivo (Bvg vivo phase) from the Bvg phase variation continuum well-described from in vitro studies cannot be excluded. Bvg vivo is likely to be BvgAS dependent, and have a 'rheostat-like gradual control,' similar to Bvg phase variation observed in vitro.
If B. bronchiseptica are growing in a biofilm-like state in the nasal cavity, bacteria may be detaching from nasal epithelia as part of a biofilm developmental life cycle. Many in vitro biofilm systems have been observed to cycle through steps of surface attachment, biofilm formation and development, and detachment of a smaller population of cells from the main biofilm body (Hall-Stoodley & Stoodley, 2005) . Bordetella bronchiseptica biofilm development can also be envisioned to follow similar life cycles. The only proposed roles of Bvg i phase has been attributed to transmission of Bordetella from one host to another (Cotter & Miller, 1997) , and such detachment may contribute to transmission if bacteria exit the respiratory tract, or to the persistent chronic nature of B. bronchiseptica infection if bacteria are inhaled into the lower respiratory tract (Irie et al., 2004) . Adhesion to cilia in the nasal cavity may also be critical for bacterial spread within and across hosts since the maximum fluid flow dynamics can be expected on ciliated surfaces, and shear force has been shown to play a significant role in biofilm detachment and dispersion (Hall-Stoodley & Stoodley, 2005) .
Nasal mucosal surface has unique properties that make drug treatments less effective, such as lower diffusion rates (Donovan et al., 1990) and rapid mucociliary clearance (Schipper et al., 1991) . Clearance of chronic persistent pathogenic species colonizing the nasal cavity is a medically challenging future issue. Further studies of B. bronchiseptica in the nose will benefit in better understanding of long-term colonizations of pathogens in the hosts.
